Contraception in Patients with Rheumatic Disease

Area of Science:

• Reproductive health
• Rheumatology
• Obstetrics & Gynecology

Background:

• Contraception is crucial for patients with rheumatic diseases, considering risks from active disease, teratogenic drugs, and organ damage.
• Many patients with rheumatic conditions do not use effective birth control methods.
• Long-acting contraceptives offer the highest efficacy.

Purpose of the Study:

• To review contraceptive options for patients with rheumatic diseases.
• To highlight risks associated with pregnancy and certain medications in this population.
• To guide rheumatologists and gynecologists in selecting appropriate contraception.

Main Methods:

• Literature review on contraception in rheumatic diseases.
• Analysis of risks and benefits of different contraceptive methods.
• Consideration of patient-specific factors like antiphospholipid syndrome and thrombosis risk.

Main Results:

• Antiphospholipid-negative patients with stable systemic lupus erythematosus can consider combined oral contraceptives.
• Estrogen-containing contraceptives should be avoided in antiphospholipid-positive patients or those with other thrombosis risks.
• Collaborative management between rheumatologists and gynecologists is essential.

Conclusions:

• Tailored contraceptive strategies are vital for women with rheumatic diseases.
• Shared decision-making ensures the safest and most effective method is chosen.
• Addressing contraceptive needs proactively improves reproductive health outcomes.